Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter


3

Study May Yield Better Cancer Drugs, Less Chemo

Share

(Newser) – A breakthrough with cancer stem cells may lead to more potent drugs—ones that pair with chemotherapy in the sort of drug cocktail used against AIDS, reports the New York Times. If borne out, the development—in which researchers figured out how to screen for chemicals that attack only cancerous stem cells—could eventually lead to lower doses of chemo and thus less distress for patients.

The current chemo regimen has a flaw, the Times notes: While it can wipe out 99% of the cells in a tumor, it leaves behind stem cells that can cause the cancer to regenerate. The new findings, which have their share of skeptics, could allow researchers to develop precise drug combos. “We have not been able to do that yet with cancer,” said one scientist involved with the project. “But, if we could, it’s a numbers game, and we win.”

The new research screened for chemicals that directly attack cancerous stem cells.
The new research screened for chemicals that directly attack cancerous stem cells.   (AP Photo/Peter Morrison)
The finding could lead to more effective drugs to fight cancer stem cells.
The finding could lead to more effective drugs to fight cancer stem cells.   (Shutter Stock)
« Prev« Prev | Next »Next » Slideshow

You could probably lower the (chemo) doses considerably with a combination of drugs that attached specific types of cell. - Dr. Piyush B. Gupta of the Broad Institute, a Harvard-MIT collaborative

« Prev« Prev | Next »Next » Slideshow
OFF THE GRID
11.20.09
The Health-Care Wars Have Just Begun
11.19.09
Sarah Palin Deserves Some More Attention
3 comments
VIEWING:
 
kokuaguy
Aug 13, 09 9:17 PM CDT
What's the deal with this advertisement masquerading as a poll by Newsmax.com? It's sponsored by a far right website: Newsmax.co. It's very misleading and part of a campaign to label the Obama Administration "socialist." Reply
Vote up! Vote down!
+1
Spudsy
Aug 13, 09 10:13 PM CDT
Well no wonder Bush protected us from stem cell research for the last eight years. They cause cancer. Gee, it's fun to be stupid. Reply
Vote up! Vote down!
+1
BurgerKing
Aug 14, 09 9:21 AM CDT
The day we have a treatment that generates more revenue than chemo, then we'll have a new treatment. The day when the people and the government demand a cure, we'll have a cure. Reply
Vote up! Vote down!
0
LEAVE A
COMMENT Comment Policy
Facebook ConnectPost this comment to Facebook?

After connecting you will have the option to post your comment on your Facebook profile.

 

Related Newser Stories

407 Stories

Now Panel Urges Delay
in Pap Test

Docs' group advises later start, every 2 years for cervical cancer test

Nov 20, 09 7:46 AM CST
(Newser) - The screening cutbacks continue. Just days after the government announced more conservative guidelines for mammograms, a major medical body says women should begin having Pap smears for cervical cancer later and less frequently. The new guidelines from the American College of Obstetricians and Gynecologists say women don't need to be... More »

MORE ABOUT:
cancer • health • cervical cancer • gynecology • Pap smear • American College of Obstetricians and Gynecologists • older women • Pap smear guidelines

Blindness Cure Could Be 1st Human Stem Cell Trial

Biotech firm aims to reverse macular degeneration

Nov 20, 09 5:41 AM CST
(Newser) - The first-ever clinical trials of stem cell treatment of humans could be under way early next year if a Massachusetts biotech firm wins FDA approval. Advanced Cell Technology yesterday applied for a license to use embryonic stem cells left over from IVF treatment, to aid people suffering from a rare... More »

MORE ABOUT:
stem cell research • FDA • stem cells • blindness • macular degeneration • Advanced Cell Technology Inc. • embryonic stem cells

Microsoft Co-Founder
Paul Allen Battling Cancer

Billionaire, 56, given diagnosis of non-Hodgkin's lymphoma

Nov 16, 09 6:55 PM CST
(Newser) - Microsoft co-founder Paul Allen has been given a diagnosis of non-Hodgkin's lymphoma, a type of cancer that affects the immune and lymphatic systems. Allen, the 56-year-old billionaire entrepreneur who owns the NFL's Seattle Seahawks and the NBA's Portland Trail Blazers, overcame Hodgkin's disease in the 1980s—a victory his sister... More »

MORE ABOUT:
cancer • Microsoft • Portland Trail Blazers • immune system • Seattle Seahawks • Paul Allen • Hodgkin's disease • non-Hodgkin's lymphoma • Paul Allen non-Hodgkin's lymphoma

407 Stories


Science & Health 
TwitterFollow @NewserScience on Twitter

 
cancer • stem cells • chemotherapy • cancer treatment

from our news partners